194 related articles for article (PubMed ID: 26042736)
1. Open access target validation is a more efficient way to accelerate drug discovery.
Lee WH
PLoS Biol; 2015 Jun; 13(6):e1002164. PubMed ID: 26042736
[TBL] [Abstract][Full Text] [Related]
2. Precompetitive activity to address the biological data needs of drug discovery.
Sidders B; Brockel C; Gutteridge A; Harland L; Jansen PG; McEwen R; Michalovich D; Seidel H; Weiss B; Williams-Jones B; Woodwark M
Nat Rev Drug Discov; 2014 Feb; 13(2):83-4. PubMed ID: 24481293
[No Abstract] [Full Text] [Related]
3. Open innovation.
Hodson R
Nature; 2016 May; 533(7602):S53. PubMed ID: 27167389
[No Abstract] [Full Text] [Related]
4. Into the valley of death: research to innovation.
Hudson J; Khazragui HF
Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
[TBL] [Abstract][Full Text] [Related]
5. Sharing is caring: a call for a new era of rare disease research and development.
Denton N; Mulberg AE; Molloy M; Charleston S; Fajgenbaum DC; Marsh ED; Howard P
Orphanet J Rare Dis; 2022 Oct; 17(1):389. PubMed ID: 36303170
[TBL] [Abstract][Full Text] [Related]
6. Public-Private Partnerships in Lead Discovery: Overview and Case Studies.
Gottwald M; Becker A; Bahr I; Mueller-Fahrnow A
Arch Pharm (Weinheim); 2016 Sep; 349(9):692-7. PubMed ID: 27335205
[TBL] [Abstract][Full Text] [Related]
7. Open PHACTS: semantic interoperability for drug discovery.
Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
[TBL] [Abstract][Full Text] [Related]
8. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
9. Open Innovation in Drug Discovery research comes of age.
Judd DB
Drug Discov Today; 2013 Apr; 18(7-8):315-7. PubMed ID: 23220636
[No Abstract] [Full Text] [Related]
10. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
Martinez-Grau MA; Alvim-Gaston M
Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
[TBL] [Abstract][Full Text] [Related]
11. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
12. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
13. Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's Disease.
Stephenson D; Hu MT; Romero K; Breen K; Burn D; Ben-Shlomo Y; Bhattaram A; Isaac M; Venuto C; Kubota K; Little MA; Friend S; Lovestone S; Morris HR; Grosset D; Sutherland M; Gallacher J; Williams-Gray C; Bain LJ; Avilés E; Marek K; Toga AW; Stark Y; Forrest Gordon M; Ford S
J Parkinsons Dis; 2015; 5(3):581-94. PubMed ID: 26406139
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
[TBL] [Abstract][Full Text] [Related]
16. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
17. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
18. [Consideration on Academia Environments for Creating Medical Innovation].
Iida K; Ishida T; Nishimura N
Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
[TBL] [Abstract][Full Text] [Related]
19. Open innovation in neuroscience research and drug discovery.
Hunter AJ; Lee WH; Bountra C
Brain Neurosci Adv; 2018; 2():2398212818799270. PubMed ID: 32166150
[TBL] [Abstract][Full Text] [Related]
20. Leveraging crowdsourcing to facilitate the discovery of new medicines.
Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH
Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
